Nature Communications (Aug 2021)
A transcription-based mechanism for oncogenic β-catenin-induced lethality in BRCA1/2-deficient cells
Abstract
Germline mutations in BRCA1 or BRCA2 tumour suppressor genes predispose to different cancers, as does oncogene activation. Here the authors reveal that aberrant transcription of specific genes triggered by activation of the oncogene β-catenin causes replication failure and cell death in the context of BRCA1/2 deficiency.